A new treatment for sexually-transmitted diseases seems to be slowing an STI epidemic — but not everyone can get it ...

Doxycycline postexposure prophylaxis (doxyPEP) initiation is associated with decreases in sexually transmitted infections (STIs).

Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...

The early rollout of doxyPEP — a dose of the antibiotic doxycycline after sex — has contributed to a decline in sexually ...

The rates of chlamydia and syphilis declined dramatically among individuals living with HIV who were prescribed doxycycline ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...

Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you. Daily news – Get the most important news from ...

While the use of PrEP has helped drop the rates of HIV infections, instances of syphilis and chlamydia among queer men have ...

Researchers have found in a new new study that Doxycycline post-exposure prophylaxis was effective strategy for reducing ...

A new study tracked thousands of gay men taking PrEP and DoxyPEP.  A new study tracked thousands of gay men taking PrEP and ...

Jan. 15, 2025 — Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. ... New Innovative Local Treatment ...

"These findings suggest that doxyPEP may offer substantial benefits for reducing population-level STI transmission with broader implementation." HealthDay News — Doxycycline postexposure ...